Childhood Grade III Lymphomatoid Granulomatosis

10 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Childhood Grade III Lymphomatoid Granulomatosis

Record	Firm	Date
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant (NCT01959477)	Case Comprehensive Cancer Center	2014-03-01
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827)	Roswell Park Cancer Institute	2012-02-28
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919)	National Cancer Institute (NCI)	2011-01-01
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (NCT01053494)	Wake Forest University Health Sciences	2010-04-01
Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (NCT00458731)	National Cancer Institute (NCI)	2007-05-01
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270)	National Cancer Institute (NCI)	2005-03-01
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT00101205)	National Cancer Institute (NCI)	2004-11-01
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858)	Fred Hutchinson Cancer Center	2003-09-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)	Fred Hutchinson Cancer Center	1999-11-01

Track Childhood Grade III Lymphomatoid Granulomatosis automatically

Every clearance here is in the API, with alerts when new ones post.